Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2011 2
2012 8
2013 12
2014 19
2015 27
2016 33
2017 26
2018 23
2019 17
2020 28
2021 30
2022 70
2023 56
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

319 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19 : A Target Trial Emulation Study.
Wan EYF, Yan VKC, Mok AHY, Wang B, Xu W, Cheng FWT, Lai FTT, Chui CSL, Li X, Wong CKH, Li PH, Cowling BJ, Hung IFN, Lau CS, Wong ICK, Chan EWY. Wan EYF, et al. Among authors: wong ckh. Ann Intern Med. 2023 Apr;176(4):505-514. doi: 10.7326/M22-3057. Epub 2023 Mar 14. Ann Intern Med. 2023. PMID: 36913693 Free PMC article. Clinical Trial.
Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study.
Wong CKH, Au ICH, Lau KTK, Lau EHY, Cowling BJ, Leung GM. Wong CKH, et al. Lancet. 2022 Oct 8;400(10359):1213-1222. doi: 10.1016/S0140-6736(22)01586-0. Lancet. 2022. PMID: 36216007 Free PMC article.
Real-world effectiveness of early molnupiravir or nirmatrelvir-ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study.
Wong CKH, Au ICH, Lau KTK, Lau EHY, Cowling BJ, Leung GM. Wong CKH, et al. Lancet Infect Dis. 2022 Dec;22(12):1681-1693. doi: 10.1016/S1473-3099(22)00507-2. Epub 2022 Aug 24. Lancet Infect Dis. 2022. PMID: 36029795 Free PMC article.
Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study.
Xiong X, Lui DTW, Chung MSH, Au ICH, Lai FTT, Wan EYF, Chui CSL, Li X, Cheng FWT, Cheung CL, Chan EWY, Lee CH, Woo YC, Tan KCB, Wong CKH, Wong ICK. Xiong X, et al. Among authors: wong ckh. PLoS Med. 2023 Jul 24;20(7):e1004274. doi: 10.1371/journal.pmed.1004274. eCollection 2023 Jul. PLoS Med. 2023. PMID: 37486927 Free PMC article.
Nowcasting epidemics of novel pathogens: lessons from COVID-19.
Wu JT, Leung K, Lam TTY, Ni MY, Wong CKH, Peiris JSM, Leung GM. Wu JT, et al. Among authors: wong ckh. Nat Med. 2021 Mar;27(3):388-395. doi: 10.1038/s41591-021-01278-w. Epub 2021 Mar 15. Nat Med. 2021. PMID: 33723452 Review.
319 results